99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma - PubMed (original) (raw)
. 2012 May 7;9(5):1409-17.
doi: 10.1021/mp200661t. Epub 2012 Apr 11.
Affiliations
- PMID: 22452411
- DOI: 10.1021/mp200661t
99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma
Zhaofei Liu et al. Mol Pharm. 2012.
Abstract
We recently designed and synthesized a Glu-c(RGDyK)-bombesin (RGD-BBN) heterodimeric peptide exhibiting a dual integrin α(v)β(3) and gastrin-releasing peptide receptor (GRPR) targeting property. In this study, we investigated whether (99m)Tc-labeled RGD-BBN peptide could be used for the noninvasive detection of lung carcinoma by using small-animal single-photon emission computed tomography (SPECT)/CT. RGD-BBN peptide was conjugated with 6-hydrazinonicotinyl (HYNIC) and then radiolabeled with (99m)Tc using tricine and TPPTS as the coligands (TPPTS = trisodium triphenylphosphine-3,3',3"-trisulfonate). The biodistribution, planar gamma imaging, and small-animal SPECT/CT studies of (99m)Tc-HYNIC(tricine)(TPPTS)-RGD-BBN ((99m)Tc-RGD-BBN) were performed in C57/BL6 mice bearing Lewis lung carcinoma (LLC) or bearing both inflammation and LLC. HYNIC-RGD-BBN possessed a dual integrin α(v)β(3) and GRPR binding capacity. (99m)Tc-RGD-BBN was prepared with a high radiochemical purity (>98%), and it exhibited specific tumor imaging with high contrast to the contralateral background. (99m)Tc-RGD-BBN was superior to (18)F-FDG for distinguishing lung carcinoma from inflammation. The uptake of (99m)Tc-RGD-BBN in LLC xenografts was 2.69 ± 0.66% ID/g at 1 h postinjection (p.i.) and was decreased to 1.99 ± 0.61% ID/g at 2 h p.i. The inflammation uptake of (99m)Tc-RGD-BBN was 1.20 ± 0.32% ID/g at 1 h and 0.56 ± 0.17% ID/g at 2 h p.i., respectively. High pancreas uptake (25.76 ± 5.49%ID/g and 19.56 ± 6.78% ID/g at 1 and 2 h p.i., respectively) was also found due to the high GRPR expression of this organ. Small-animal SPECT/CT using (99m)Tc-RGD-BBN can specifically detect the LLC pulmonary metastases. Our results suggested that SPECT/CT with (99m)Tc-RGD-BBN would provide an effective approach for the noninvasive detection of lung cancer.
Similar articles
- [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R. Decristoforo C, et al. Nucl Med Biol. 2006 Nov;33(8):945-52. doi: 10.1016/j.nucmedbio.2006.09.001. Nucl Med Biol. 2006. PMID: 17127166 - 99mTc-Hydrazinonicotinyl(tricine)(TPPTS)-Glu-c(RGDyK)-bombesin[7-14]NH2.
Leung K. Leung K. 2012 Aug 16 [updated 2012 Nov 8]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2012 Aug 16 [updated 2012 Nov 8]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 23166958 Free Books & Documents. Review. - 99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer.
Shi J, Jia B, Liu Z, Yang Z, Yu Z, Chen K, Chen X, Liu S, Wang F. Shi J, et al. Bioconjug Chem. 2008 Jun;19(6):1170-8. doi: 10.1021/bc700471z. Epub 2008 May 21. Bioconjug Chem. 2008. PMID: 18491928 - 99mTc-(Hydrazinonicotinic acid-β-Ala-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2)(tricine)(TPPTS).
Leung K. Leung K. 2008 Oct 25 [updated 2008 Dec 12]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2008 Oct 25 [updated 2008 Dec 12]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641678 Free Books & Documents. Review.
Cited by
- Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy.
Guo Y, Li Y, Zhang M, Ma R, Wang Y, Weng X, Zhang J, Zhang Z, Chen X, Yang W. Guo Y, et al. Nat Commun. 2024 Oct 4;15(1):8586. doi: 10.1038/s41467-024-53010-0. Nat Commun. 2024. PMID: 39362879 Free PMC article. - Radiolabeled NGR-Based Heterodimers for Angiogenesis Imaging: A Review of Preclinical Studies.
Trencsényi G, Halmos G, Képes Z. Trencsényi G, et al. Cancers (Basel). 2023 Sep 7;15(18):4459. doi: 10.3390/cancers15184459. Cancers (Basel). 2023. PMID: 37760428 Free PMC article. Review. - Cancer discrimination by on-cell N-glycan ligation.
Nomura S, Egawa Y, Urano S, Tahara T, Watanabe Y, Tanaka K. Nomura S, et al. Commun Chem. 2020 Feb 26;3(1):26. doi: 10.1038/s42004-020-0270-9. Commun Chem. 2020. PMID: 36703447 Free PMC article. - Multifunctional self-assembled peptide nanoparticles for multimodal imaging-guided enhanced theranostic applications against glioblastoma multiforme.
Rizvi SFA, Ali A, Ahmad M, Mu S, Zhang H. Rizvi SFA, et al. Nanoscale Adv. 2021 Sep 15;3(20):5959-5967. doi: 10.1039/d1na00597a. eCollection 2021 Oct 12. Nanoscale Adv. 2021. PMID: 36132681 Free PMC article. - Radionuclide-Based Imaging of Breast Cancer: State of the Art.
Li H, Liu Z, Yuan L, Fan K, Zhang Y, Cai W, Lan X. Li H, et al. Cancers (Basel). 2021 Oct 30;13(21):5459. doi: 10.3390/cancers13215459. Cancers (Basel). 2021. PMID: 34771622 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical